Mi Deng

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 14

Top Topics

Acute Myeloid Leukemia

Cell Cycle Arrest

Allogeneic Hematopoietic Stem Cell Transplantation

Diffusion Weighted

Top Venues

Cancer immunology research

Antibody therapeutics

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Ryan Huang, Xiaoye Liu, Jaehyup Kim, Hui Deng, Mi Deng, Xun Gui, Heyu Chen, Guojin Wu, Wei Xiong, Jingjing Xie, Cheryl M Lewis, Jade Homsi, Xing Yang, Chengcheng Zhang, Yubo He, Qi Lou, Caroline Smith, Samuel John, Ningyan Zhang, Zhiqiang An, Cheng Cheng Zhang
LILRB3 Supports Immunosuppressive Activity of Myeloid Cells and Tumor Development. Cancer immunology research 12 (3) (2024)
Ryan Huang, Xiaoye Liu, Jaehyup Kim, Hui Deng, Mi Deng, Xun Gui, Heyu Chen, Guojin Wu, Wei Xiong, Jingjing Xie, Cheryl M Lewis, Jade Homsi, Xing Yang, Chengcheng Zhang, Yubo He, Qi Lou, Caroline Smith, Samuel John, Ningyan Zhang, Zhiqiang An, Cheng Cheng Zhang
LILRB3 Supports Immunosuppressive Activity of Myeloid Cells and Tumor Development. Cancer immunology research 12 (3) (2024)
Ryan Huang, Xiaoye Liu, Jaehyup Kim, Hui Deng, Mi Deng, Xun Gui, Heyu Chen, Guojin Wu, Wei Xiong, Jingjing Xie, Cheryl M Lewis, Jade Homsi, Xing Yang, Chengcheng Zhang, Yubo He, Qi Lou, Caroline Smith, Samuel John, Ningyan Zhang, Zhiqiang An, Cheng Cheng Zhang
LILRB3 Supports Immunosuppressive Activity of Myeloid Cells and Tumor Development. Cancer immunology research 12 (3) (2024)
Ryan Huang, Xiaoye Liu, Jaehyup Kim, Hui Deng, Mi Deng, Xun Gui, Heyu Chen, Guojin Wu, Wei Xiong, Jingjing Xie, Cheryl M Lewis, Jade Homsi, Xing Yang, Chengcheng Zhang, Yubo He, Qi Lou, Caroline Smith, Samuel John, Ningyan Zhang, Zhiqiang An, Cheng Cheng Zhang
LILRB3 Supports Immunosuppressive Activity of Myeloid Cells and Tumor Development. Cancer immunology research 12 (3) (2024)
Ryan Huang, Xiaoye Liu, Jaehyup Kim, Hui Deng, Mi Deng, Xun Gui, Heyu Chen, Guojin Wu, Wei Xiong, Jingjing Xie, Cheryl M Lewis, Jade Homsi, Xing Yang, Chengcheng Zhang, Yubo He, Qi Lou, Caroline Smith, Samuel John, Ningyan Zhang, Zhiqiang An, Cheng Cheng Zhang
LILRB3 Supports Immunosuppressive Activity of Myeloid Cells and Tumor Development. Cancer immunology research 12 (3) (2024)
Jianbo Wu, Fuqing Meng, Danyang Ran, Yalong Song, Yunkun Dang, Fan Lai, Longyan Yang, Mi Deng, Yuqin Song, Jun Zhu
The Metabolism and Immune Environment in Diffuse Large B-Cell Lymphoma. Metabolites 13 (6) (2023)
Rui Peng, Mi Deng
Mapping the protein-protein interactome in the tumor immune microenvironment. Antibody therapeutics 6 (4) (2023)
Jianbo Wu, Fuqing Meng, Danyang Ran, Yalong Song, Yunkun Dang, Fan Lai, Longyan Yang, Mi Deng, Yuqin Song, Jun Zhu
The Metabolism and Immune Environment in Diffuse Large B-Cell Lymphoma. Metabolites 13 (6) (2023)
Rui Peng, Mi Deng
Mapping the protein-protein interactome in the tumor immune microenvironment. Antibody therapeutics 6 (4) (2023)
Ryan Huang, Xiaoye Liu, Jaehyup Kim, Hui Deng, Mi Deng, Xun Gui, Heyu Chen, Guojin Wu, Wei Xiong, Jingjing Xie, Cheryl M Lewis, Jade Homsi, Xing Yang, Chengcheng Zhang, Yubo He, Qi Lou, Caroline Smith, Samuel John, Ningyan Zhang, Zhiqiang An, Cheng Cheng Zhang
LILRB3 supports immunosuppressive activity of myeloid cells and tumor development. Cancer immunology research (2023)
Jianbo Wu, Fuqing Meng, Danyang Ran, Yalong Song, Yunkun Dang, Fan Lai, Longyan Yang, Mi Deng, Yuqin Song, Jun Zhu
The Metabolism and Immune Environment in Diffuse Large B-Cell Lymphoma. Metabolites 13 (6) (2023)
Mi Deng, Heyu Chen, Xiaoye Liu, Ryan Huang, Yubo He, Byounggyu Yoo, Jingjing Xie, Samuel John, Ningyan Zhang, Zhiqiang An, Cheng Cheng Zhang
Leukocyte immunoglobulin-like receptor subfamily B: therapeutic targets in cancer. Antibody therapeutics 4 (1) (2021)
Yasuaki Anami, Mi Deng, Xun Gui, Aiko Yamaguchi, Chisato M Yamazaki, Ningyan Zhang, Zhiqiang An, Kyoji Tsuchikama
LILRB4-targeting Antibody-Drug Conjugates for the Treatment of Acute Myeloid Leukemia. Molecular cancer therapeutics 19 (11) (2020)
Xun Gui, Mi Deng, Hao Song, Yuanzhi Chen, Jingjing Xie, Zunling Li, Licai He, Fangfang Huang, Yixiang Xu, Yasuaki Anami, Hai Yu, Chenyi Yu, Leike Li, Zihao Yuan, Xiaoying Xu, Qihui Wang, Yan Chai, Tao Huang, Yi Shi, Kyoji Tsuchikama, X Charlene Liao, Ning-Shao Xia, George F Gao, Ningyan Zhang, Cheng Cheng Zhang, Zhiqiang An
Disrupting LILRB4/APOE Interaction by an Efficacious Humanized Antibody Reverses T-cell Suppression and Blocks AML Development. Cancer immunology research 7 (8) (2019)